Insider · CIK 0001740730

Reitan Colleen F

Reports to the SEC for 2 companies · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001740730

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+59.7K sh	—	—	152,030
2026-05-20	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director	AAward	+671 sh	—	—	1,446
2026-05-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,441 sh	—	—	1,441
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$100.65	+$1.81M	18,775
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,645 sh	$457.44	−$752K	17,130
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,888 sh	$458.86	−$866K	15,242
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,403 sh	$459.73	−$645K	13,839
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−473 sh	$460.71	−$218K	13,366
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,290 sh	$461.92	−$1.06M	11,076
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,652 sh	$463.00	−$765K	9,424
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−799 sh	$464.36	−$371K	8,625
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−222 sh	$471.25	−$105K	8,403
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−823 sh	$472.82	−$389K	7,580
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−838 sh	$474.22	−$397K	6,742
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−951 sh	$474.85	−$452K	5,791
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−972 sh	$476.31	−$463K	4,819
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,183 sh	$477.47	−$565K	3,636
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,450 sh	$478.67	−$694K	2,186
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,386 sh	$479.55	−$665K	800
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−25 sh	$480.98	−$12K	775
2025-09-09	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2025-06-05	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+49.8K sh	—	—	92,329
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director	AAward	+775 sh	—	—	775
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+1,558 sh	—	—	1,558
2025-04-16	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−36 sh	$232.86	−$8,382.96	0
2024-10-17	ALNYALNYLAM PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+4 sh	$302.67	+$1,210.68	36
2024-09-03	MYGNMYRIAD GENETICS INCS Sale	Director	SSale	−46K sh	$27.95	−$1.29M	42,533
2024-08-29	ALNYALNYLAM PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+32 sh	$286.00	+$9,152	32
2024-06-06	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+15.7K sh	—	—	88,545
2024-05-16	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,228 sh	—	—	5,228
2023-06-01	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+15.2K sh	—	—	72,850
2023-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,454 sh	—	—	3,454
2022-06-02	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+17.3K sh	—	—	57,699
2022-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,153 sh	—	—	5,153
2021-07-15	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,032 sh	—	—	4,032
2021-06-03	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+12.8K sh	—	—	40,424
2020-12-04	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+15.9K sh	—	—	27,576
2020-07-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,581 sh	—	—	4,581
2019-12-05	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+11.7K sh	—	—	11,687
2019-07-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2018-06-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000

Recent filings

Accepted (ET)
Jun 54
Reitan Colleen F0001740730-26-000002
SEC(opens sec.gov)
May 224
Reitan Colleen F0001178670-26-000040
SEC(opens sec.gov)
Sep 114
Reitan Colleen F0001735276-25-000097
SEC(opens sec.gov)

Companies

Address

322 NORTH 2200 WEST

SALT LAKE CITY, UT, 84116